Legal Alliance defended client's rights to IBUPROM MAX trademark, settled dispute amicably

Partner at Legal Alliance Illya Kostin and attorney-at-law Anastasia Hrachova represented a client in a court proceeding on partial invalidation of Ukraine's Health Ministry's orders on the registration of medicines, the name of which is similar to the IBUPROM MAX trademark, owned by the U.S. Pharmacia International, Inc. pharmaceutical company of the United States. Due to a well-formed defense strategy, the attorneys-at-law achieved a successful and prompt solution to the proceeding by concluding an amicable agreement.

The defendants in the proceeding, two internal pharmaceutical companies, admitted they had violated the intellectual property rights of the client of Legal Alliance and remedied the violations in advance, before the court ruling approved the amicable agreement. In particular, they changed the names of medicines and stopped production under controversial titles, which was the condition for concluding the amicable agreement.

Earlier, Legal Alliance Company successfully represented the interests of the Berlin-Chemie (Menarini Group) German pharmaceutical company in a similar dispute over the Espumisan trademark. Experience in this well-known case on the market, to a certain extent, contributed to the conclusion of the amicable agreement in the dispute over the protection of rights to the IBUPROM MAX trademark.

An amicable agreement, in contrast to a court proceeding, is a quick and less costly way of settling a dispute as well as has advantages for both parties of the process.